Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
ekincare has raised a total funding of $22M since 2015 till date
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
First and only PARP inhibitor to improve overall survival in early breast cancer
Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The product will be marketed by Dr. Reddy's
Subscribe To Our Newsletter & Stay Updated
